What's in Fundação Pró Rim's pipeline?

Fundação Pró Rim has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Fundação Pró Rim's portfolio?

Top competitors by shared drug class: Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Guangxi Medical University, Haukeland University Hospital, Imperial College Healthcare NHS Trust, Jinnah Postgraduate Medical Centre.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/funda-o-pr-rim.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Fundação Pró Rim — Portfolio Competitive Intelligence Brief

Fundação Pró Rim pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Everolimus+Tacrolimus+Prednisone	Everolimus+Tacrolimus+Prednisone	marketed	Immunosuppressive combination therapy	mTOR (everolimus), calcineurin (tacrolimus), glucocorticoid receptor (prednisone)	Immunology / Transplantation
Mycophenolate+Tacrolimus+Prednisone	Mycophenolate+Tacrolimus+Prednisone	marketed	Immunosuppressive combination therapy	T-cell proliferation and activation (multiple targets: IMPDH, calcineurin, glucocorticoid receptor)	Immunology / Transplantation

Therapeutic area mix

Immunology / Transplantation · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Federal Research Institute of Pediatric Hematology, Oncology and Immunology · 1 shared drug class
Guangxi Medical University · 1 shared drug class
Haukeland University Hospital · 1 shared drug class
Imperial College Healthcare NHS Trust · 1 shared drug class
Jinnah Postgraduate Medical Centre · 1 shared drug class
Novartis · 1 shared drug class
Pfizer · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundação Pró Rim:

Cite this brief

Drug Landscape (2026). Fundação Pró Rim — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/funda-o-pr-rim. Accessed 2026-05-16.